Sinovac Biotech Ltd (NASDAQ:SVA)

5.55
Data as of Jul 25
 -0.16 / -2.80%
Today’s Change
3.85
Today|||52-Week Range
8.14
-9.31%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Biotechnology
MARKET CAP
$308.4M

Company Description

Sinovac Biotech Ltd. is biopharmaceutical company that focuses on research, development, manufacturing and commercialization of vaccines that protect against human infectious diseases including hepatitis A and B, seasonal influenza, H5N1 pandemic influenza and mumps, as well as animal rabies vaccine. Its products include Healive, Bilive, Anflu, Panflu and PANFLU.1. The company was founded in 1993 and is headquartered in Beijing, China.

Contact Information

Sinovac Biotech Ltd.
No. 39 Shangdi Xi Road
Beijing Beijing 100085
P:861082890088
Investor Relations:
8610827998719659

Employees

Shareholders

Mutual fund holders6.28%
Other institutional22.08%
Individual stakeholders--

Top Executives

Wei Dong YinChairman, President, CEO & Secretary
Nan WangChief Financial Officer
Ming XiaVice President-Sales & Marketing
Xue Feng WangHead-International Sales
Helen G. YangHead-Investor Relations

To view my watchlist

Not a member yet?

Sign up now for a free account
Market indexes are shown in real time, except for the DJIA, which is delayed by two minutes. All times are ET. Disclaimer Morningstar: © 2014 Morningstar, Inc. All Rights Reserved. Disclaimer The Dow Jones IndexesSM are proprietary to and distributed by Dow Jones & Company, Inc. and have been licensed for use. All content of the Dow Jones IndexesSM © 2014 is proprietary to Dow Jones & Company, Inc. Chicago Mercantile Association. The market data is the property of Chicago Mercantile Exchange Inc. and its licensors. All rights reserved. FactSet Research Systems Inc. 2014. All rights reserved. Most stock quote data provided by BATS.